Valerie L Traina, MD
General Surgery · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 6 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
26 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Traina’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A49393 · Current
Licensed to practise in California · since 1991 · expires 2027-03-31 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Forest Surgery Center LPAmbulatory Surgery Center · San Jose, CAOwner · accredited by JCAccreditation Renewed1 inspection, 1 with deficiencies · last 2012-09-18: Requirements Met
- Knowles Surgery Center, LLCAmbulatory Surgery Center · Los Gatos, CA5.2% owner since 2012 · accredited by AAAASFProbation3 inspections, 2 with deficiencies · last 2017-05-23: Requirements Met
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$113,509
Medicare paid this office $113,509 for 189 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 157 | $32,740 | $115 |
| Long return visit (40+ min) | 47 | $10,103 | $163 |
| Ultrasound scan of head and neck soft tissue | 45 | $5,561 | $113 |
| New patient visit (45+ min) | 25 | $3,858 | $154 |
| New patient visit (60+ min) | 18 | $3,405 | $189 |
See all 12 services
| Return visit (30+ min) | 157 | $32,740 | $115 |
| Long return visit (40+ min) | 47 | $10,103 | $163 |
| Ultrasound scan of head and neck soft tissue | 45 | $5,561 | $113 |
| New patient visit (45+ min) | 25 | $3,858 | $154 |
| New patient visit (60+ min) | 18 | $3,405 | $189 |
| Biopsy or removal of deep lymph nodes of underarm | 13 | $2,592 | $199 |
| Limited ultrasound scan of 1 breast | 19 | $2,591 | $89 |
| Short return visit (20+ min) | 25 | $2,464 | $88 |
| Imaging of lymph nodes during surgery | 14 | $1,612 | $115 |
| Ultrasonic guidance for needle placement | 11 | $716 | $51 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 18 | $601 | $29 |
| Injection of radioactive material for x-ray identification of lymph node | 14 | $194 | $14 |
Procedures Medicare counted
| Mastectomy | 20 | More than 79% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
189 Original Medicare patients in 2024. Average age 77 · Women 89% · Health risk score 0.89. At or below the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 69% · Cancer 58% · Diabetes 24% · Atrial fibrillation 19% · Coronary heart disease 18% · Depression 13% · Heart failure 8% · Chronic kidney disease 8% · Stroke 7%.
The office billed $383,300, Medicare allowed $146,995 and paid $113,509; for 669 services of 43 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 189 | 669 | 77 | 0.89 | $383,300 | $113,509 |
| 2023 | 180 | 637 | 76 | 0.91 | $331,985 | $109,838 |
| 2022 | 171 | 660 | 77 | 0.90 | $369,677 | $119,484 |
| 2021 | 163 | 634 | 76 | 0.89 | $315,858 | $115,310 |
| 2020 | 152 | 458 | 76 | 0.88 | $245,040 | $77,417 |
| 2019 | 185 | 645 | 76 | 1.01 | $392,990 | $118,635 |
| 2018 | 187 | 549 | 75 | 1.03 | $245,030 | $72,365 |
| 2017 | 196 | 624 | 75 | 0.99 | $372,000 | $109,279 |
| 2016 | 177 | 581 | 75 | 0.99 | $291,095 | $85,847 |
| 2015 | 188 | 569 | 74 | 0.97 | $256,155 | $77,265 |
| 2014 | 200 | 718 | 74 | 0.78 | $370,985 | $114,657 |
| 2013 | 192 | 615 | 74 | 0.77 | $249,300 | $91,531 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 144 | $28,603 | $117 |
| Long return visit (40+ min) | 49 | $10,182 | $164 |
| Ultrasound scan of head and neck soft tissue | 44 | $6,092 | $119 |
| Measurement of lymphedema extracellular fluid | 25 | $4,385 | $141 |
| New patient visit (45+ min) | 25 | $3,877 | $155 |
| New patient visit (60+ min) | 18 | $3,726 | $207 |
| Short return visit (20+ min) | 20 | $2,087 | $87 |
| Limited ultrasound scan of 1 breast | 13 | $1,689 | $89 |
| Ultrasonic guidance for needle placement | 15 | $862 | $48 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 11 | $383 | $29 |
2022: 12 services
| Return visit (30+ min) | 142 | $28,720 | $118 |
| Long return visit (40+ min) | 37 | $8,751 | $168 |
| Measurement of lymphedema extracellular fluid | 35 | $8,423 | $156 |
| Ultrasound scan of head and neck soft tissue | 44 | $6,682 | $121 |
| New patient visit (60+ min) | 18 | $3,754 | $209 |
| New patient visit (45+ min) | 19 | $2,995 | $158 |
| Short return visit (20+ min) | 17 | $1,844 | $88 |
| Limited ultrasound scan of 1 breast | 17 | $1,785 | $89 |
| Imaging of lymph nodes during surgery | 13 | $1,714 | $122 |
| Ultrasonic guidance for needle placement | 14 | $814 | $54 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 17 | $542 | $30 |
| Injection of radioactive material for x-ray identification of lymph node | 12 | $196 | $15 |
2021: 8 services
| Return visit (30+ min) | 146 | $33,408 | $122 |
| Measurement of lymphedema extracellular fluid | 46 | $10,870 | $162 |
| Ultrasound scan of head and neck soft tissue | 43 | $6,074 | $124 |
| Limited ultrasound scan of 1 breast | 22 | $3,901 | $91 |
| Long return visit (40+ min) | 20 | $3,841 | $175 |
| New patient visit (45+ min) | 25 | $3,717 | $149 |
| Short return visit (20+ min) | 18 | $1,873 | $89 |
| Short return visit | 15 | $840 | $49 |
2020: 7 services
| Return visit (30+ min) | 134 | $19,930 | $97 |
| Ultrasound scan of head and neck soft tissue | 41 | $5,638 | $117 |
| Long return visit (40+ min) | 24 | $4,151 | $130 |
| Measurement of lymphedema extracellular fluid | 18 | $2,918 | $154 |
| New patient visit (45+ min) | 16 | $1,978 | $124 |
| Limited ultrasound scan of 1 breast | 14 | $1,896 | $90 |
| Short return visit (20+ min) | 12 | $1,112 | $69 |
2019: 11 services
| Return visit (30+ min) | 160 | $27,075 | $94 |
| Ultrasound scan of head and neck soft tissue | 53 | $6,883 | $113 |
| Long return visit (40+ min) | 25 | $4,060 | $123 |
| Limited ultrasound scan of 1 breast | 24 | $3,706 | $84 |
| New patient visit (45+ min) | 20 | $2,655 | $133 |
| Short return visit (20+ min) | 25 | $1,966 | $66 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 14 | $1,875 | $117 |
| Imaging of lymph nodes during surgery | 14 | $1,583 | $113 |
| Extended office or other outpatient service, first hour | 13 | $1,475 | $113 |
| Ultrasonic guidance for needle placement | 15 | $904 | $53 |
| Placement of locating device in breast using ultrasound guidance, first growth | 11 | $412 | $37 |
2018: 7 services
| Return visit (30+ min) | 166 | $23,067 | $88 |
| Ultrasound scan of head and neck soft tissue | 55 | $7,889 | $114 |
| New patient visit (45+ min) | 26 | $3,456 | $133 |
| Short return visit (20+ min) | 33 | $2,873 | $65 |
| Long return visit (40+ min) | 14 | $2,636 | $120 |
| Limited ultrasound scan of 1 breast | 17 | $2,056 | $82 |
| Fine needle aspiration using imaging guidance | 13 | $1,971 | $131 |
2017: 9 services
| Return visit (30+ min) | 173 | $22,990 | $83 |
| Ultrasound scan of head and neck soft tissue | 51 | $6,443 | $109 |
| Limited ultrasound scan of 1 breast | 29 | $3,676 | $80 |
| Removal of growth of breast identified by x-ray marker, first growth | 12 | $2,761 | $230 |
| Long return visit (40+ min) | 18 | $2,731 | $124 |
| New patient visit (45+ min) | 19 | $2,592 | $136 |
| New patient visit (60+ min) | 14 | $2,381 | $170 |
| Short return visit (20+ min) | 29 | $2,119 | $64 |
| Ultrasonic guidance for needle placement | 16 | $1,263 | $55 |
2016: 7 services
| Return visit (30+ min) | 164 | $24,133 | $92 |
| Ultrasound scan of head and neck soft tissue | 47 | $6,625 | $112 |
| Short return visit (20+ min) | 36 | $3,361 | $66 |
| Fine needle aspiration using imaging guidance | 16 | $2,928 | $133 |
| Limited ultrasound scan of 1 breast | 19 | $2,459 | $85 |
| New patient visit (45+ min) | 17 | $2,453 | $144 |
| Ultrasonic guidance for needle placement | 15 | $1,131 | $57 |
2015: 8 services
| Return visit (30+ min) | 168 | $23,972 | $96 |
| Ultrasound scan of head and neck soft tissue | 44 | $6,167 | $116 |
| Fine needle aspiration using imaging guidance | 17 | $4,064 | $135 |
| Short return visit (20+ min) | 47 | $3,908 | $63 |
| Long return visit (40+ min) | 13 | $2,828 | $129 |
| Limited ultrasound scan of 1 breast | 22 | $2,425 | $87 |
| New patient visit (45+ min) | 16 | $2,217 | $139 |
| Ultrasonic guidance for needle placement | 12 | $662 | $47 |
2014: 11 services
| Return visit (30+ min) | 175 | $24,938 | $94 |
| Ultrasound scan of head and neck soft tissue | 50 | $7,951 | $124 |
| Long return visit (40+ min) | 27 | $6,523 | $128 |
| Short return visit (20+ min) | 39 | $4,063 | $62 |
| Removal of growth of breast identified by x-ray marker, first growth | 12 | $3,864 | $322 |
| New patient visit (45+ min) | 24 | $3,412 | $142 |
| Ultrasound of breasts | 17 | $2,600 | $100 |
| Ultrasonic guidance for needle placement | 25 | $2,500 | $71 |
| Fine needle aspiration using imaging guidance | 12 | $2,313 | $136 |
| Extended office or other outpatient service, first hour | 15 | $1,799 | $90 |
| Imaging of lymph nodes during surgery | 11 | $1,409 | $117 |
2013: 8 services
| Return visit (30+ min) | 167 | $21,565 | $91 |
| Ultrasound scan of head and neck soft tissue | 44 | $8,264 | $122 |
| Ultrasonic guidance for needle placement | 21 | $7,884 | $207 |
| Fine needle aspiration using imaging guidance | 16 | $4,307 | $135 |
| Long return visit (40+ min) | 19 | $4,174 | $130 |
| Short return visit (20+ min) | 43 | $3,295 | $67 |
| Ultrasound of breasts | 25 | $2,988 | $91 |
| New patient visit (45+ min) | 22 | $2,926 | $133 |
Drugs they prescribed that Part D paid
$216
Pharmacies billed $216 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 50% of their Part D prescriptions (17 of 34) in 2024. Too few prescriptions to compare fairly with other clinicians.
34 generic and 0 brand-name prescriptions · $216 in drug cost · 16 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 14 | $62 | $4 |
| Cephalexin | 11 | $32 | $3 |
Year by year
| 2024 | 34 | 24 | 50% (17) | 0% | $216 |
| 2023 | 27 | 18 | 52% (14) | 0% | $148 |
| 2022 | 26 | 18 | 54% (14) | 0% | $194 |
| 2021 | 18 | 14 | None | 0% | $162 |
| 2020 | 28 | 14 | None | 0% | $346 |
| 2019 | 28 | 15 | 46% (13) | 0% | $185 |
| 2018 | 14 | None | None | 0% | $77 |
| 2017 | 23 | 15 | None | 0% | $228 |
| 2016 | 20 | 13 | None | 0% | $213 |
| 2015 | 13 | None | None | 0% | $110 |
| 2014 | 24 | 16 | 46% (11) | None | $314 |
| 2013 | 25 | None | None | None | $267 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Cephalexin | 12 | $88 | $7 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 12 | $64 | $5 |
2017: 1 drug
| Cephalexin | 12 | $106 | $9 |
Money from drug and device companies
$154 in 2025
| 2025 | 2 | 2 | None | $154 |
| 2024 | 3 | 4 | None | $238 |
| 2023 | 4 | 5 | None | $375 |
| 2022 | 2 | 2 | None | $67 |
| 2021 | 5 | 9 | $500 | $902 |
| 2020 | 2 | 3 | None | $107 |
| 2019 | 6 | 6 | None | $249 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $125 | 1 payment
|
| Solventum | 3m Duraprep Surgical | $29 | 1 payment
|
See all 2 published payments
| Solventum | Meals · 2025-06-16 | 3m Duraprep Surgical | $29 |
| Astellas Pharma US | Meals · 2025-01-30 | Veozah | $125 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $238
| Astellas Pharma US | Veozah | $112 | 1 payment
|
| TELA Bio | Ovitex 2s | $88 | 1 payment
|
| Myriad Genetic Laboratories | Myrisk | $38 | 2 payments
|
2023: $375
| Endomagnetics | Magseed | $170 | 1 payment
|
| Mayne Pharma Commercial | Nextstellis | $122 | 1 payment
|
| Sirius Medical Systems | Pintuition | $68 | 2 payments
|
| Ethicon US | Megadyne | $15 | 1 payment
|
2022: $67
| Merit Medical Systems | Savi Scout | $41 | 1 payment
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $25 | 1 payment
|
2021: $902
| ImpediMed | None | $500 | 1 payment
|
| Endomagnetics | Magseed | $186 | 1 payment
|
| Merit Medical Systems | Savi Scout | $174 | 5 payments
|
| AcelRx Pharmaceuticals | Dsuvia | $21 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $21 | 1 payment
|
2020: $107
| Endomagnetics | Magseed | $64 | 1 payment
|
| Acell | None | $43 | 1 payment
|
2019: $249
| Medtronic USA | Kyphon Balloon Kyphoplasty | $83 | 1 payment
|
| Elucent Medical | None | $71 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $27 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Vitrakvi | $24 | 1 payment
|
| Genentech USA | Perjeta | $24 | 1 payment
|
| Tactile Systems Technology | Flexitouch | $20 | 1 payment
|
Professional record
- NPI
- 1447384698
- Licence
- CA A49393California A49393: Current · expires 2027-03-31
- Trained
- Tufts University School of Medicine, 1981
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 320 Dardanelli Ln Ste 17, Los Gatos, CA, 95032
- NPI first listed
- 2007-03-16
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.